IQVIA HOLDINGS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 219.2 USD | -0.57% |
|
+0.06% | -5.25% |
| Jun. 06 | Goldman Sachs Initiates IQVIA With Buy Rating, $270 Price Target | MT |
| May. 28 | Weight-loss drug forecasts jump to $150 billion as supply grows | RE |
Chart calendar Iqvia Holdings Inc.
aa66bb250289fa8e5a3b.U6XfYbUYZN6tKMPk63EQQNXa0mBJNYrqQoD3SArBtl0.KvqWJMJNXZveYLDTkjN_d7SroA4MVOGYAfmPP06XhTFqkvIG_noz6cZ7hg~e24dd89672fc6a322968979e51881b33
Upcoming events on Iqvia Holdings Inc.
Past events on Iqvia Holdings Inc.
| 2024-05-14 12:20 pm | BofA Securities Health Care Conference |
| 2024-05-02 09:00 am | Q1 2024 Earnings Call |
| 2024-05-02 07:00 am | Q1 2024 Earnings Release |
| 2024-04-16 09:00 am | Annual General Meeting |
| 2024-03-13 09:30 am | Barclays Global Healthcare Conference |
| 2024-02-29 09:30 am | Citi Unplugged Medtech and Life Sciences Access Day |
| 2024-02-14 09:00 am | Q4 2023 Earnings Call |
| 2024-02-14 07:00 am | Q4 2023 Earnings Release |
| 2023-11-29 10:50 am | Evercore ISI HealthCONx Conference |
| 2023-11-01 09:00 am | Q3 2023 Earnings Call |
| 2023-11-01 07:00 am | Q3 2023 Earnings Release |
| 2023-09-13 10:50 am | Baird Global Healthcare Conference |
| 2023-09-12 11:30 am | Morgan Stanley Global Healthcare Conference |
| 2023-08-01 09:00 am | Q2 2023 Earnings Call |
| 2023-08-01 07:00 am | Q2 2023 Earnings Release |
| 2023-04-27 09:00 am | Q1 2023 Earnings Call |
| 2023-04-27 07:00 am | Q1 2023 Earnings Release |
| 2023-04-18 09:00 am | Annual General Meeting |
| 2023-03-15 09:30 am | Barclays Global Healthcare Conference |
| 2023-02-10 09:00 am | Q4 2022 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 11 088 11 042 0.42% | 11 359 11 202 1.4% | 13 874 13 830 0.32% | 14 410 14 387 0.16% | 14 984 14 910 0.5% | 15 481 |
|
EBITDA Million USD | Released Forecast Spread | 2 400 2 401 -0.04% | 2 384 2 347 1.59% | 3 022 2 993 0.98% | 3 346 3 342 0.13% | 3 569 3 566 0.08% | 3 732 |
|
EBIT Million USD | Released Forecast Spread | 2 112 2 112 -0% | 2 030 1 990 2.03% | 2 591 2 537 2.11% | 2 779 2 846 -2.36% | 3 050 3 028 0.72% | 3 142 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 352 429 -18.04% | 373 392 -4.84% | 1 128 1 089 3.61% | 1 363 1 540 -11.51% | 1 459 1 518 -3.9% | 1 638 |
|
Net income Million USD | Released Forecast Spread | 191 306 -37.67% | 279 331 -15.7% | 966 922 4.75% | 1 091 1 219 -10.47% | 1 358 1 226 10.77% | 1 335 |
|
EPS USD | Released Forecast Spread | 0,96 1,53 -37.36% | 1,43 1,70 -16.02% | 4,95 4,73 4.6% | 5,72 6,35 -9.97% | 7,29 6,53 11.7% | 7,33 |
| Announcement Date | 12/02/20 | 10/02/21 | 15/02/22 | 10/02/23 | 14/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3 568 3 539 0.82% | 3 541 3 493 1.36% | 3 562 3 545 0.47% | 3 739 3 713 0.71% | 3 652 3 608 1.22% | 3 728 3 708 0.53% | 3 736 3 777 -1.08% | 3 868 3 797 1.88% | 3 737 3 705 0.86% | 3 793 | 3 876 | 4 068 | 4 001 | 4 098 |
|
EBITDA Million USD | Released Forecast Spread | 812 804 1% | 800 796 0.48% | 814 808 0.71% | 920 913 0.75% | 851 849 0.21% | 864 860 0.47% | 888 886 0.21% | 966 963 0.32% | 862 863 -0.16% | 884 | 956 | 1 038 | 927 | 974 |
|
EBIT Million USD | Released Forecast Spread | 691 683 1.14% | 682 673 1.31% | 694 686 1.18% | 712 783 -9.11% | 721 723 -0.25% | 737 726 1.56% | 747 753 -0.86% | 821 821 0.02% | 738 728 1.42% | 746 | 799 | 871 | 790 | 822 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 400 404 -1.07% | 328 406 -19.21% | 360 373 -3.57% | 275 472 -41.68% | 362 363 -0.33% | 375 368 1.79% | 349 379 -7.98% | 373 430 -13.34% | 340 358 -4.97% | 372 | 426 | 504 | 414 | 453 |
|
Net income Million USD | Released Forecast Spread | 325 298 8.89% | 256 281 -8.86% | 283 271 4.6% | 227 354 -35.88% | 289 290 -0.3% | 297 283 4.93% | 303 294 3.04% | 469 333 40.65% | 288 283 1.75% | 304 | 346 | 407 | 328 | 361 |
|
EPS USD | Released Forecast Spread | 1,68 1,57 6.77% | 1,34 1,47 -9.04% | 1,49 1,47 1.03% | 1,20 1,87 -35.81% | 1,53 1,52 0.63% | 1,59 1,50 6.2% | 1,63 1,58 3.37% | 2,54 1,77 43.5% | 1,56 1,48 5.29% | 1,62 | 1,85 | 2,19 | 1,83 | 2,01 |
| Announcement Date | 27/04/22 | 21/07/22 | 26/10/22 | 10/02/23 | 27/04/23 | 01/08/23 | 01/11/23 | 14/02/24 | 02/05/24 | - | - | - | - | - |
| 2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
| 2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
| 2024-07-26 01:00 am | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Iqvia Holdings Inc.
| 2024-05-29 04:01 pm | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
| 2024-05-23 07:00 am | CUREVAC N.V.: Q1 2024 Earnings Release |
| 2024-05-22 01:00 am | EVOTEC SE: Q1 2024 Earnings Release |
| 2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
| 2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 am | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | KYVERNA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- IQV Stock
- Calendar Iqvia Holdings Inc.
